SEARCH

SEARCH BY CITATION

References

  • 1
    World Health Organization Task Force on Post-ovulatory Methods for Fertility Regulation. Termination of pregnancy with reduced doses of mifepristone. BMJ 1993;307:5327.
  • 2
    World Health Organization Task Force on Post-ovulatory Methods for Fertility Regulation. Comparison of two doses of mifepristone in combination of misoprostol for early medical abortion: a randomized trial. BJOG 2000;107:52430.
  • 3
    World Health Organization Task Force on Post-ovulatory Methods for Fertility Regulation. Medical abortion at 57 to 63 days’ gestation with a lower dose of mifepristone and gemeprost: a randomized controlled trial. Acta Obstet Gynecol Scand 2001;80:44751.
  • 4
    World Health Organization Task Force on Post-ovulatory Methods for Fertility Regulation. Pregnancy termination with mifepristone and gemeprost: a multicentre comparison between repeated doses and a single dose of mifepristone. Fertil Steril 1991;56:3240.
  • 5
    World Health Organization Task Force on Post-ovulatory Methods for Fertility Regulation. Lowering the doses of mifepristone and gemeprost for early abortion: a randomised controlled trial. BJOG 2001;108:73842.
  • 6
    Heikinheimo O, Kekkonen R. Dose-response relationship of RU 486. Ann Med 1993;25:716.
  • 7
    Bygdeman M, Swahn ML. Progesterone receptor blockage–effect on uterine contractility and early pregnancy. Contraception 1985;32:4551.
  • 8
    Ashok PW, Flett GM, Templeton A. Mifepristone versus vaginally administered misoprostol for cervical priming before first-trimester termination of pregnancy: a randomized, controlled study. Am J Obstet Gynecol 2000;183:9981002.
  • 9
    Ulmann A, Silvestre L, Chemama L, Rezvani Y, Renault M, Aguillaume CJ, et al. Medical termination of early pregnancy with mifepristone (RU486) followed by a prostaglandin analogue. Study in 16,369 women. Acta Obstet Gynecol Scand 1992;71:27883.
  • 10
    Schaff EA, Fielding SL, Westhoff C, Ellertson C, Eisinger SH, Stadalius LS, et al. Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion: a randomized trial. JAMA 2000;284:194853.
  • 11
    Creinin MD, Schreiber CA, Bednarek P, Lintu H, Wagner M-S, Meyn LA for the MAST Study Trial Group. Mifepristone and misoprostol administered simultaneously versus 24 hours apart for abortion. Obstet Gynecol 2007;109:88594.
  • 12
    Guest J, Chien PF, Thomson MA, Kosseim ML. Randomized controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36-48 hour protocol. BJOG 2007;114:20715.
  • 13
    Piaggio G, Elbourne DR, Altman DG, Pocock SJ, Evans SJ; CONSORT Group. Reporting of noninferiority and equivalence randomized trials: an extention of the CONSORT statement. JAMA 2006;295:115260.
  • 14
    Creinin MC, Pymar HC, Schwartz JL. Mifepristone 100 mg in abortion regimens. Obstet Gynecol 2001;98:4349.
  • 15
    Aronsson A, Bygdeman M, Gemzell-Danielsson K. Effects of mifepristone on uterine contractility following different routes of administration. Hum Reprod 2004;19:814.
  • 16
    Heikinheimo O, Suhonen S, Haukkamaa M. One-and two-day mifepristone-misoprostol intervals are both effective in medical termination of second trimester pregnancy. Reprod Biomed Online 2004;8:2369.
  • 17
    von Hertzen H, Piaggio G, Huong NT, Arustamyan K, Cabezas E, Gomez M, et al. Efficacy of two intervals and two routes of administration of misoprostol for termination of early pregnancy: a randomized controlled equivalence trial. Lancet 2007;369:193846.
  • 18
    von Hertzen H, Honkanen H, Piaggio G, Bartfai G, Erdenetungalag R, Gemzell-Danielsson K, et al. WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion: I Efficacy. BJOG 2003;110:80818.
  • 19
    Suhonen S, Heikinheimo O, Tikka M, Haukkamaa M. The learning curve is rapid in medical termination of pregnancy–first year results from the Helsinki area. Contraception 2003;67:2237.